References
- Halikas J A, Nugent S M, Crosby R D, et al. 1990–1991 survey of pharmacotherapies used in the treatment of cocaine abuse. J Addict Dis 1993; 12: 129–139
- Arndt I, McLellan A T, Dorozynsky L, et al. Desipramine treatment for cocaine dependence. J Nerv MentDis 1994; 182: 151–156
- Batki S L, Manfredi L B, Jacob P, et al. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J Clin Psychopharmacol 1993; 13: 243–250
- Glassman A H, Preud'homme X A. Review of the cardiovascular effects of heterocyclic antidepressants. J Clin Psychiatry 1993; 54: 16–22
- Messiha F S. Fluoxetine: adverse effects and drug‐drug interactions. J Toxicol Clin Toxicol 1993; 31: 603–630
- Walsh B T, Giardina E G, Sloan R P, et al. Effects of desipramine on autonomic control of the heart. J Am Acad Child Adolesc Psychiatry 1994; 33: 191–197
- Regier D A, Farmer M E, Rae D S, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990; 264: 2511–2518
- Levin F R, Lehman A F. Meta‐analysis of desipramine as an adjunct in the treatment of cocaine addiction. J Clin Psychopharmacol 1991; 11: 374–378
- Fischman M W, Foltin R W, Nestadt G, et al. Effects of desipramine maintenance on cocaine self‐administration by humans. J Pharmacol Exp Ther 1990; 253: 760–770
- Kosten T K, Gawin F H, Silverman D G, et al. Intravenous cocaine challenges during desipramine maintenance. Neuropsychopharmacology 1992; 7: 169–176
- Walsh S L, Preston K L, Sullivan J T, et al. Fluoxetine alters die effects of intravenous cocaine in humans. J Clin Psychopharmacol 1994; 14: 396–407
- Cone F J, Menchen S L, Paul B D, et al. Validity testing of commercial urine cocaine‐metabolite assays, I: assay detection times, individual excretion patterns, and kinetics after cocaine administration to humans. J Forensic Sci 1989; 34: 15–31
- DuPont W D, Plummer W D. Power and Sample Size Calculations: A Review and Computer Program. Elsevier, New York 1990; 116–128
- Orsulak P J. Therapeutic monitoring of antidepressant drugs: current methodology and applications. J Clin Psychiatry 1986; 47: 39–52
- DeVane C L. Pharmacokinetics of die selective serotonin reuptake inhibitors. J Clin Psychiatry 1992; 53: 13–20
- Preskorn S H, Silkey B, Beber J, et al. Antidepressant response and plasma concentrations of fluoxetine. Ann Clin Psychiatry 1991; 3: 147–151
- Chakko S, Myerburg R J. Cardiac complications of cocaine abuse. Clin Cardiol 1995; 18: 67–72